A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

Viatris

Status: Completed

Conditions: Posttraumatic Stress Disorder

Treatments: Drug: sertraline (Zoloft)

Study type: Observational

Funder types: Industry

Identifiers

NCT01607593

A0501099

Details and patient eligibility

About

This is a multicenter retrospective study to investigate the dosage regimens of sertraline in the treatment of Posttraumatic Stress Disorder (PTSD) under current medical practice and the efficacy and safety of this drug in patients with PTSD. Data will be collected from the medical records of patients with PTSD.

Full description

Patients with PTSD who have been dosed with sertraline from July 2006 (i.e., the start of marketing of this drug in Japan) or later to before contracting with each investigational site.

Enrollment: 123 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with PTSD who have been dosed with sertraline since July 2006 or later.
• Patients must be Japanese.
• Patients should be started before the conclusion of a contract with each investigational site.

Exclusion criteria

• Not applicable.

Trial design

123 participants in 1 patient group

sertraline (Zoloft)

Treatment:

Drug: sertraline (Zoloft)